Driving a decade of change: HIV/AIDS, patents and access to medicines for all

E Hoen, J Berger, A Calmy, S Moon - Journal of the International AIDS …, 2011 - Springer
Since 2000, access to antiretroviral drugs to treat HIV infection has dramatically increased to
reach more than five million people in developing countries. Essential to this achievement …

Promoting versatile vaccine development for emerging pandemics

JT Monrad, JB Sandbrink, NG Cherian - npj Vaccines, 2021 - nature.com
The ongoing COVID-19 pandemic has demonstrated the importance of rapid and versatile
development of emergency medical countermeasures such as vaccines. We discuss the role …

[HTML][HTML] Global health governance at a crossroads

NY Ng, JP Ruger - Global health governance: the scholarly journal …, 2011 - ncbi.nlm.nih.gov
This review takes stock of the global health governance (GHG) literature. We address the
transition from international health governance (IHG) to global health governance, identify …

Rethinking the'global'in global health: a dialectic approach

K Bozorgmehr - Globalization and health, 2010 - Springer
Background Current definitions of'global health'lack specificity about the term'global'. This
debate presents and discusses existing definitions of'global health'and a common problem …

Innovation and access to medicines for neglected populations: could a treaty address a broken pharmaceutical R&D system?

S Moon, J Bermudez, E 't Hoen - PLoS Medicine, 2012 - journals.plos.org
As part of a cluster of articles leading up to the 2012 World Health Report and critically
reflecting on the theme of “no health without research,” Suerie Moon and colleagues argue …

Orphan drugs policies: a suitable case for treatment

M Drummond, A Towse - The European Journal of Health Economics, 2014 - Springer
Context Current orphan drug policies are unsatisfactory when viewed from almost all
perspectives. Patients find that, although therapies are available for many rare conditions …

The efficacy and tolerability of 'polypills': meta-analysis of randomised controlled trials

CR Elley, AK Gupta, R Webster, V Selak, M Jun… - PloS one, 2012 - journals.plos.org
Background To assess the blood pressure and lipid-lowering efficacy and tolerability of
'polypills' used in cardiovascular disease prevention trials. Methodology/Principal Findings …

[PDF][PDF] Drug-resistant infection: Causes, consequences, and responses

E Jamrozik, MJ Selgelid - Ethics and drug resistance: Collective …, 2020 - library.oapen.org
This chapter provides an overview of the causes and consequences of, and possible policy
responses to, the problem of drug resistance. Throughout, we highlight the ways that ethical …

[图书][B] Cosmopolitan responsibility

JC Heilinger - 2019 - library.oapen.org
The world we live in is unjust. Preventable deprivation and suffering shape the lives of many
people, while others enjoy advantages and privileges aplenty. Cosmopolitan responsibility …

[PDF][PDF] National, regional, and sectoral systems of innovation–an overview

B Schrempf, D Kaplan… - Report for FP7 Project « …, 2013 - progressproject.eu
An innovation system: can be defined as a group of private firms, public research institutes,
and several of the facilitators of innovation, who in interaction promote the creation of one or …